Richard A Young's Net Worth
$2.72 Million
Who is Richard A Young?
Richard A Young has an estimated net worth of $2.72 Million. This is based on reported shares across multiple companies, which include Omega Therapeutics, Inc., ENZON PHARMACEUTICALS INC, and Syros Pharmaceuticals, Inc..
SEC CIK
Richard A Young's CIK is 0001490283
Past Insider Trading and Trends
2022 was Richard A Young's most active year for acquiring shares with 4 total transactions. Richard A Young's most active month to acquire stocks was the month of May. 2020 was Richard A Young's most active year for disposing of shares, totalling 12 transactions. Richard A Young's most active month to dispose stocks was the month of July. 2024 saw Richard A Young paying a total of $0.00 for 35,000 shares, this is the most they've acquired in one year. In 2019 Richard A Young cashed out on 25,000 shares for a total of $250,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Omega Therapeutics, Inc. (OMGA) Snapshot price: $1.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| -0.67% | -5.00K |
$8.00 | -$40,000.00 | 739.12K |
Jun 2
| |||
Form 4
| -0.67% | -5.00K |
$8.00 | -$40,000.00 | 744.12K |
May 1
| |||
Form 4
| -0.66% | -5.00K |
$8.00 | -$40,000.00 | 749.12K |
Apr 6
| |||
Form 4
| -1.31% | -10.00K |
$8.00 | -$80,000.00 | 754.12K |
Mar 17
| |||
Form 4
| -2.55% | -20.00K |
$8.00 | -$160,000.00 | 764.12K |
Scheduled
|
Jan 10
| ||
Form 4
| -1.26% | -10.00K |
$8.00 | -$80,000.00 | 784.12K |
Scheduled
|
Sep 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENZON PHARMACEUTICALS INC (ENZN) Snapshot price: $0.1601
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +54.54% | 10.67K |
—
|
—
| 30.23K |
Jul 2
| |||
Form 4
| -9.28% | -2.00K |
$6.92 | -$13,842.20 | 19.56K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +52.06% | 7.38K |
—
|
—
| 21.56K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +98.68% | 7.04K |
—
|
—
| 14.18K |
Jul 1
| |||
Form 4
|
∞
| 7.14K |
—
|
—
| 7.14K |
Apr 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Syros Pharmaceuticals, Inc. (SYRS) Snapshot price: $1.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +33.34% | 2.67K |
—
|
—
| 10.67K |
Sep 16
| |||
Form 4
| -81.32% | -34.84K |
$5.12 | -$178,365.44 | 8K |
Jun 28
| |||
Form 4
| +10.30% | 4K |
—
|
—
| 42.84K |
Jun 5
| |||
Form 4
| +7.37% | 2.67K |
—
|
—
| 38.84K |
Sep 16
| |||
Form 4
| +12.43% | 4K |
—
|
—
| 36.17K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| -1.15% | -3.75K |
$12.05 | -$45,187.50 | 321.71K |
Scheduled
|
Feb 16
| ||
Form 4
| -1.14% | -3.75K |
$13.04 | -$48,900.00 | 325.46K |
Scheduled
|
Feb 8
| ||
Form 4/A
| -1.79% | -5.99K |
$8.77 | -$52,558.09 | 329.21K |
Scheduled
|
Nov 16 - Nov 17
| ||
Form 4
| -1.74% | -5.99K |
$8.77 | -$52,558.09 | 339.21K |
Scheduled
|
Nov 16 - Nov 17
| ||
Form 4
| -1.66% | -5.67K |
$8.75 | -$49,638.75 | 335.2K |
Scheduled
|
Oct 19
| ||
Form 4
| -0.09% | -317.00 |
$8.75 | -$2,773.75 | 340.87K |
Scheduled
|
Oct 15
| ||
Form 4
| -1.73% | -5.99K |
$10.39 | -$62,236.10 | 341.19K |
Scheduled
|
Sep 15
| ||
Form 4
| -1.70% | -5.99K |
$12.59 | -$75,414.10 | 347.18K |
Scheduled
|
Aug 17
| ||
Form 4
| -1.67% | -5.99K |
$11.85 | -$70,981.50 | 353.17K |
Scheduled
|
Jul 15
| ||
Form 4
| -1.64% | -5.99K |
$8.75 | -$52,412.50 | 359.16K |
Scheduled
|
Jun 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| -1.61% | -5.99K |
$9.22 | -$55,242.18 | 365.15K |
Scheduled
|
May 15
| ||
Form 4
| -6.06% | -23.96K |
$8.75 | -$209,650.00 | 371.14K |
Scheduled
|
Apr 15
| ||
Form 4
| -5.95% | -25.00K |
$10.00 | -$250,000.00 | 395.1K |
Scheduled
|
Aug 15 - Aug 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| -0.78% | -3.28K |
$22.00 | -$72,204.00 | 420.1K |
Scheduled
|
Aug 14
| ||
Form 4
| -0.77% | -3.28K |
$22.09 | -$72,495.77 | 423.38K |
Scheduled
|
Jul 25
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Camp4 Therapeutics Corp (CAMP) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +6.11% | 8.92K |
—
|
—
| 154.86K |
Oct 15
| |||
| No matching records found | |||||||||